Breast Cancer

Most Cancer Patients Are Wary of Estrogen Replacement

Published in Cancer Weekly, September 16th, 1996

In the selection of participants for a study of estrogen replacement therapy in women with a history of localized breast cancers, interviewers found that women in this group "... harbor considerable reluctance regarding [estrogen replacement therapy] for the management of menopausal health concerns."

Dr. Rena Vassilopoulou-Sellin and Mary Jean Klein interviewed 137 women who met criteria for the study. They report that one-third of those women were apprehensive about the previously reported risks associated with hormone therapy.

Vassilopoulou-Sellin and colleague found that 17 percent of the women interviewed were willing to enroll in the study. ...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1996-09-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry